Q4 2022 Holdings
Filed 2023-02-09 | 684 holdings | $956.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sylvamo Corp(SLVM) | COMMON STOCK | 871332102 | $104.5M | 2,150,000 | 10.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $95.2M | 4,288,366 | 9.9% |
| DCP Midstream LP | COM UT LTD PTN | 23311P100 | $58.8M | 1,516,562 | 6.2% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $56.2M | 856,654 | 5.9% |
| Revance Therapeutics Inc | NOTE 1.750% 2/1 | 761330AB5 | $34.3M | $36,600,000 | 3.6% |
| Cutera Inc(CUTREUR) | COM | 232109108 | $29.7M | 671,309 | 3.1% |
| Dish Network Corporation | NOTE 3.375% 8/1 | 25470MAB5 | $28.5M | $45,367,000 | 3.0% |
| Innoviz Technologies LTD(INVZ) | SHS | M5R635108 | $28.1M | 7,156,390 | 2.9% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $28.1M | 3,143,608 | 2.9% |
| Sumitomo Mitsui Finl Group I(SMFG) | SPONSORED ADR | 86562M209 | $27.0M | 3,370,730 | 2.8% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $26.7M | 3,732,778 | 2.8% |
| Sciplay Corporation(2XY) | CL A | 809087109 | $24.9M | 1,551,246 | 2.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $23.1M | 405,174 | 2.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $22.2M | 1,250,000 | 2.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $21.5M | 1,100,000 | 2.3% |
| Energy Transfer L P(ET) | COM UT LTD PTN | 29273V100 | $20.4M | 1,715,000 | 2.1% |
| Project Energy Reimagined AC | CLASS A ORD | G72556106 | $15.1M | 1,500,000 | 1.6% |
| Hennessy Capital Invst Corp | UNIT 99/99/9999 | 42600H207 | $14.8M | 1,500,000 | 1.5% |
| Cantaloupe Inc(CTLP) | COM | 138103106 | $12.3M | 2,821,409 | 1.3% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $9.9M | 1,361,169 | 1.0% |
| The ODP Corp(ODP1) | COM | 88337F105 | $9.3M | 204,181 | 1.0% |
| Advisorshares TR(MSOS) | PURE US CANNABIS | 00768Y453 | $9.3M | 1,323,344 | 1.0% |
| LL Flooring Holdings Inc(LLFLQ) | COM | 55003T107 | $9.1M | 1,622,000 | 1.0% |
| Kairos Acquisition Corp | CL A SHS | G52110114 | $8.8M | 869,000 | 0.9% |
| Northern Star Invest Corp II | COM CL A | 66574L100 | $7.4M | 735,000 | 0.8% |
| Alpha Healthcare Acqu Corp I | UNIT 04/01/2026 | 02073F203 | $7.0M | 700,000 | 0.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $6.9M | 748,077 | 0.7% |
| ETF Managers TR | PRIME JUNIR SLVR | 26924G102 | $6.7M | 634,629 | 0.7% |
| Pioneer Merger Corp | CL A SHS | G7S24C103 | $6.3M | 625,000 | 0.7% |
| Brookfield Reins LTD | CL A EXCH LT VTG | G16250105 | $5.8M | 185,833 | 0.6% |
| CBL & Assoc Pptys Inc(CBL) | COMMON STOCK | 124830878 | $5.8M | 250,000 | 0.6% |
| Hertz Global Hldgs Inc(HTZWW) | *W EXP 06/30/205 | 42806J148 | $5.2M | 700,355 | 0.5% |
| Osiris Acquisition Corp | CL A | 68829A103 | $5.0M | 500,000 | 0.5% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $4.4M | 16,300 | 0.5% |
| Northern Star Invest Corp IV | COM CL A | 66575B101 | $4.3M | 425,000 | 0.4% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $4.2M | 1,775,793 | 0.4% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $4.0M | 3,647,430 | 0.4% |
| SVF Investment Corp | CL A SHS | G8601L102 | $3.8M | 379,824 | 0.4% |
| Graf Acquisition Corp IV | COM | 384272100 | $3.6M | 363,598 | 0.4% |
| Burtech Acquisition Corp | CLASS A COM | 123013104 | $3.3M | 328,761 | 0.3% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $3.1M | 37,127 | 0.3% |
| Integrated Rail and RES ACQ | CL A COM | 45827R106 | $3.1M | 300,382 | 0.3% |
| Fusion Acquisition Corp II | COM CL A | 36118N102 | $3.0M | 299,870 | 0.3% |
| Ishares Inc(EWT) | MSCI TAIWAN ETF | 46434G772 | $3.0M | 74,193 | 0.3% |
| Citigroup Inc(C) | COM NEW | 172967424 | $3.0M | 65,704 | 0.3% |
| Target Corp(TGT) | COM | 87612E106 | $3.0M | 19,867 | 0.3% |
| Moderna Inc(MRNA) | COM | 60770K107 | $2.9M | 16,324 | 0.3% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $2.9M | 23,910 | 0.3% |
| Churchill Capital Corp VII | COM CL A | 17144M102 | $2.8M | 285,000 | 0.3% |
| 26 Capital Acquisition Corp | COM CL A | 90138P100 | $2.8M | 275,000 | 0.3% |